Evidence map›Paper›PMID 42274777›Full record

ArticleBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2026

[Effects of the cannabis act on supply channels, attitudes, and perceptions of users].

Larissa Steimle, Bernd Werse, Anke Stallwitz

Abstract readEnglish Abstract
In one paragraph

Article in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Larissa SteimleFakultät Sozialwissenschaften, Technische Hochschule Nürnberg Georg Simon Ohm, Nürnberg, Bayern, Deutschland. Larissa.steimle@th-nuernberg.de.
Bernd WerseFachbereich Soziale Arbeit und Gesundheit, Frankfurt University of Applied Sciences, Frankfurt, Hessen, Deutschland.
Anke StallwitzEvangelische Hochschule Freiburg, Freiburg, Baden-Württemberg, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the Cannabis Act (CanG), the German government aimed to improve health protection and to curb the illegal cannabis market. A partial success of the CanG would be evident in the shift from illegal to legal supply channels. The following questions were central: How did sources of cannabis supply change overall and across different groups due to the Cannabis Act? Which groups subjectively benefit the most from the Cannabis Act?

methodsTo address these research questions, a non-representative, quantitative online survey was conducted from 24 March 2025 to 10 June 2025 among cannabis users aged 14 and older. Participants were asked about their sources of supply before and after the Cannabis Act took effect as well as the subjectively perceived effects. The sample included N = 11,471 participants.

resultsSince the CanG came into effect, a shift from illegally to legally produced cannabis has been observed among adults overall, particularly among men and people in rural areas, as home cultivation and pharmacy purchases have increased significantly. In contrast, little change was observed among adolescents. Participants reported predominantly positive subjective effects of the law. Gender and regional differences showed that men and residents of major cities-particularly Berlin and Hamburg-more frequently perceived positive subjective effects. DISCUSSION: The results suggest that certain subgroups face barriers in accessing the legal market, including adolescents, women, and the urban population. For these groups, targeted measures aimed at reducing such barriers could contribute to further curbing illegal sources of supply.

Indexed as

CannabisCommerceLegislation, DrugMarijuana SmokingAdolescentAdultFemaleGermanyHumansMaleMiddle AgedYoung AdultCannabisDrug policyHome cultivationIllegal marketPharmacy

Identifiers

PMID42274777
PMCPMC13323109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.